Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 3
Submit an article Journal homepage
192
Views
8
CrossRef citations to date
0
Altmetric
Letter to the Editor

A simple score based on geriatric assessment predicts survival in elderly newly diagnosed chronic lymphocytic leukemia patients

Stefano MolicaDepartment of Oncology/Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy; Correspondence[email protected]
,
Diana GiannarelliBiostatistic Unit, IRCCS Regina Elena, Rome, Italy
,
Luciano LevatoDepartment of Oncology/Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy;
,
Rosanna MirabelliDepartment of Oncology/Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy;
,
Domenico LevatoDepartment of Oncology/Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy;
,
Mirella LentiniDepartment of Oncology/Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy;
&
Eugenio PiroDepartment of Oncology/Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy;
show all
Pages 845-847 | Received 30 Jun 2018, Accepted 29 Jul 2018, Published online: 02 Oct 2018

References

  • Yamamoto JF, Goodman MT. Pattern of leukemia in the United States by subtype and demographic characteristics. Cancer Causes Control. 2008;19:379–390.
  • Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116:3724–3734.
  • Thurmes P, Call T, Slager S, et al. Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. Leuk Lymph. 2008;49:49–56.
  • Goede V, Fischer K, Busch R, et al. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med. 2014;370:1101–1110.
  • Hillmen P, Robak T, Janssens A, et al. Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial. Lancet. 2015;385:1873–1883.
  • Burger JA, Tedeschi A, Barr PM, et al. Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia. N Engl J Med. 2015;373:2425–2437.
  • Stauder B, Eichhorst ME, Hamaker K, et al. Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an International Society of Geriatric Oncology (SIOG) Task Force. Ann Oncol. 2017;28:218–227.
  • Goede V, Bahlo J, Chataline V, et al. Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: results of the CLL9 trial of the German CLL study group. Leuk Lymph. 2016;57:789–796.
  • Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111:5446–5456.
  • Furman RR, Sharman JP, Coutre SE, et al. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. N Engl J Med. 2014;370:997–1007.
  • Stilgenbauer S, Eichhorst B, Schetelig J, et al. Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study. Lancet Oncol. 2016;17:768–778.
  • Seymour JF, Kipps TJ, Eichhorst B, et al. Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia. N Engl J Med. 2018;378:1107–1120. 22

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.